It is noted that the agreement was signed with the AstraZeneca developer.
The agreement provides the purchase of 300 million doses of vaccine for all countries-members of the European Union. The purchase of the next 100 million doses is also provided.
Moreover, the European Commission plans to sign similar agreements with another four developers – GSK, Johnson & Johnson, CureVac and Moderna.
The vaccine against coronavirus developed by AstraZeneca is at the large-scale clinical trials of II/III phases after promising results at the I/II phases in safety and immunogenicity.
As of August 27, 112,059 cases of coronavirus infection were registered in Ukraine. Over the last 24 hours, 1,978 people have been diagnosed with the disease. A total of 2,403 people died as a result of complications caused by the disease (+49 per day, which is the highest number of deaths that has been observed since the beginning of the pandemic), 53,454 patients have already managed to recover - a repeated laboratory study did not detect the virus.
Besides, a record daily increase in the number of deaths from the coronavirus infection was reported in Ukraine - 49 people.